Home > Healthcare > Pharmaceuticals > Finished Drug Form > Methotrexate Drugs Market

Methotrexate Drugs Market Size

Report ID: GMI9756
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Methotrexate Drugs Market Size

Methotrexate Drugs Market size was valued at around USD 590.4 million in 2023 and is estimated to grow at 3.1% CAGR from 2024 to 2032. Methotrexate drugs is a versatile medication with a wide range of therapeutic applications. Originally developed as a chemotherapy agent for treating cancer, it has since found extensive use in the management of autoimmune disorders and inflammatory conditions due to its immunosuppressive and anti-inflammatory properties.

To get key market trends

Download Free Sample

It works by inhibiting the enzymes dihydrofolate reductase, which is involved in the synthesis of DNA, RNA, and proteins. By interfering with folate metabolism, methotrexate disrupts the proliferation of rapidly dividing cells, including cancer cells and cells of the immune system responsible for inflammation in autoimmune diseases.

The rising prevalence of cancer is a significant driving factors for the market. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. Thus, this underscores the urgent need for effective treatments such as cancer immunotherapy, driving its demand and market growth.

Furthermore, ongoing research and development using methotrexate, which is estimated to reach USD 921 million by 2032, drugs, rising technological advancements and demand for personalized medicine, are the promoting factors fostering the growth of the market.

Methotrexate Drugs Market Report Attributes
Report Attribute	Details
Base Year:	2023
Methotrexate Drugs Market Size in 2023:	USD 590.4 Million
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	3.1%
2024 – 2032 Value Projection:	USD 775.1 Million
Historical Data for:	2021 – 2023
No. of Pages:	265
Tables, Charts & Figures:	343
Segments covered:	Indication, Drug Type, Drug Form, Route of Administration, Distribution Channel, and Region
Growth Drivers:	Increasing prevalence of cancer Ongoing research and development using methotrexate drugs Rising technological advancements and demand for personalized medicine
Pitfalls & Challenges:	Adverse effects and safety concerns Limited reimbursement and coverage policies

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global methotrexate drugs industry size was valued at USD 590.4 billion in 2023 and is estimated to grow at 3.1% CAGR from 2024 to 2032 due to increasing prevalence of cancer and the ongoing R&D using methotrexate drugs.

The cancer segment of the market is forecasted to reach USD 263.4 million by 2032 due to its effectiveness in treating various cancers, especially leukemia and metastatic breast cancer.

The hospital pharmacies segment of the methotrexate drugs market recorded USD 248.6 million in 2023 due to the need for provide specialized methotrexate formulations and follow robust safety protocols to enhance patient care and safety in clinical settings.

Accord Healthcare, Amneal Pharmaceuticals LLC, Apotex Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, and Merck KGaA, among others.